Andrew Vaino, Ph.D. has been our Chief Scientific Officer since 2015. Dr. Vaino received his Ph.D. in chemistry from Queen’s University and his MBA from the University of California, Irvine.
Andrew Vaino, Ph.D. has been our Chief Scientific Officer since 2015. Dr. Vaino received his Ph.D. in chemistry from Queen’s University and his MBA from the University of California, Irvine.
All Rights Reserved.
© 2024 LB Pharmaceuticals. , a development stage life sciences company whose lead compound, LB-102, is a proprietary, patented version of amisulpride.